Summary & Overview
CPT 80361: Opiate and Narcotic Analgesic Toxicology Analysis
CPT code 80361 documents laboratory testing to detect or quantify one or more opiates and narcotic analgesics in a patient specimen. This toxicology-focused laboratory service is used in clinical care, pain management monitoring, substance use evaluation, and forensic or workplace testing. Nationally, opiate toxicology testing remains important for population health surveillance, opioid-safety programs, and payer coverage policy development.
Key payers commonly involved in coverage and reimbursement considerations include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers can expect a concise overview of the code’s clinical purpose and typical use cases, a summary of which major payers cover the service, and context for where this test is performed. The publication also outlines typical service settings and practical considerations for documentation and coding clarity.
This summary does not provide state-specific guidance. Data not available in the input for specific payer reimbursement rates, associated taxonomies, ICD-10 pairings, or related CPT/HCPCS codes.
Billing Code Overview
CPT code 80361 describes a laboratory procedure in which a lab analyst measures the amount of, or detects the presence of, one or more opiates and narcotic analgesics that depress the central nervous system in a clinical specimen. This service is a toxicology/urine drug test type of laboratory analysis used to identify exposure to opiate-class substances.
-
Service type: Clinical laboratory toxicology analysis for opiates/narcotic analgesics
-
Typical site of service: Clinical laboratory or hospital laboratory; specimens are commonly collected in outpatient clinics, hospitals, or other ambulatory collection sites
Clinical & Coding Specifications
Clinical Context
A 38-year-old patient presents to an outpatient pain management clinic for monitoring while receiving opioid therapy for chronic low back pain. The clinician orders a urine specimen to screen for presence of prescribed and non-prescribed opiates as part of a controlled substance monitoring program. The specimen is collected in the clinic, sent to the clinical laboratory, and the laboratory analyst performs an immunoassay or confirmatory analytical method to measure or detect one or more opiates/narcotic analgesics in the sample. Results are reported to the ordering provider and documented in the patient record as part of ongoing medication management and compliance assessment. Typical sites of service include hospital laboratories, independent clinical laboratories, ambulatory surgery centers that perform perioperative testing, and outpatient clinic lab draws.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when reporting only the professional (interpretive) component if the lab splits technical and professional services and the professional component is billed separately. |
52 | Reduced services | Use if only a portion of the test was performed or a truncated/limited testing panel was provided. |
53 | Discontinued procedure | Use if testing was started but discontinued due to specimen issues or inability to complete analysis. |
59 | Distinct procedural service | Use when this laboratory test is distinct and separate from other services on the same day to indicate a separate encounter or clinical purpose. |
62 | Two surgeons | Typically not used for lab tests, but may apply when billing cross-specialty surgical teams that also request intraoperative testing. |
78 | Return to operating room | Rare for this code; use only when testing is ordered in relation to an immediate return to OR. |
90 | Reference (outside) laboratory | Use when the performing laboratory is a reference lab and the ordering provider wants that indicated on the claim. |
91 | Repeat clinical diagnostic laboratory test | Use when a repeat test is performed on the same date to obtain a valid result after an invalid/erroneous prior run. |
TC | Technical component | Use when billing only the technical component of the laboratory analysis if split billing applies. |
QX | Ordering physician attests to services personally performed | Use when appropriate in situations with direct supervision and attestation requirements for certain testing programs. |
QY | Ordering physician attests to services personally performed under an exception | Use in similar supervisory/attestation contexts where an exception applies. |
AS | Physician assistant, nurse practitioner, or clinical nurse specialist services | Use when these clinicians order or supervise specimen collection/testing per payer rules. |
| Taxonomy Code | Specialty | Notes |
|---|---|---|
| 207P00000X | Anesthesiology | Anesthesiologists may order perioperative opioid testing or monitoring in surgical pain management. |
| 208800000X | Pathology & Laboratory Medicine | Pathologists and clinical laboratory specialists perform and oversee toxicology testing. |
| 1835S0205X | Pain Management | Pain medicine physicians commonly order opioid drug testing for chronic opioid therapy monitoring. |
| 208D00000X | Emergency Medicine | Emergency physicians order opiate testing for acute overdose evaluation and disposition. |
| 367A00000X | Addiction Medicine | Addiction specialists order and interpret opiate toxicology as part of substance use disorder care. |
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|---|---|
F11.10 | Opioid abuse, uncomplicated | Indicates opioid misuse or abuse where opiate testing may be used for diagnosis and monitoring. |
F11.20 | Opioid dependence, uncomplicated | Used in monitoring patients in treatment programs where opiate detection confirms abstinence or compliance. |
Z79.899 | Other long term (current) drug therapy | Reflects chronic opioid therapy where periodic opiate testing is part of risk mitigation and compliance. |
T40.2X1A | Poisoning by other opioids, accidental (initial encounter) | Relevant for acute overdose evaluation where opiate presence and quantity are clinically important. |
M54.5 | Low back pain | A common pain diagnosis for which patients may receive prescribed opioid analgesics and require monitoring with opiate testing. |
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|---|---|
80307 | Drug test(s), presumptive, any number of drug classes by any number of devices or procedures, qualitative, e.g., immunoassay; multiple drug classes | Often used as an initial point-of-care or laboratory immunoassay screen for opiates prior to confirmatory testing with 80361. |
80305 | Drug test(s), definitive, quantitative, or qualitative, confirmation; e.g., GC/MS, LC/MS/MS, one or more drugs or metabolites, each specimen | Represents confirmatory testing for specific opiates or metabolites after a positive screen; typically performed in the same workflow following 80361 detection. |
82570 | Drug assay(s), other than chromatographic; for drugs, each drug class | May be used for other analgesic drug classes tested in parallel with opiate detection when broader drug panels are ordered. |
99000 | Handling and/or conveyance of specimen for transfer from site of collection to laboratory (if used by some payers) | Applied when specimens are transported to a reference laboratory for opiate analysis as part of the testing workflow. |
36415 | Collection of venous blood by venipuncture | Used when confirmatory testing or quantitative assays require a blood specimen in addition to urine for opiate measurement. |